Boxer Capital Management, LLC
Insider at Tango Therapeutics; Insider at Tyra Biosciences.
- Rank
- 528th of 813
- Companies held
- 1
- Largest holding
- TNGX, 100.0% of total
- Latest SEC filing
- Nov 6, 2024
- Listed but not counted
- $456M
What the $154M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Tango Therapeutics TNGX Common Stock | Directly | 6,690,642 | $22.71 | $152M | 98.4% | Form 4, Oct 25, 2024 |
| Tango Therapeutics TNGX Common Stock | Through MVA Investors, LLC | 108,793 | $22.71 | $2.5M | 1.6% | Form 4, Nov 6, 2024 |
Share counts are the amounts Boxer Capital Management, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Boxer Capital Management, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Tango Therapeutics TNGX Common Stock | Through BCTG Holdings, LLC Counted on the profiles of the people who report this holding | 6,988,450 | $22.71 | $159M | — | Form 4, Nov 6, 2024 |
| Tyra Biosciences TYRA Common Stock | Through Boxer Capital Management, LLC Held by a company or fund the insider manages | 6,448,349 | $19.73 | $127M | — | Form 3, Oct 10, 2024 |
| Tyra Biosciences TYRA Common Stock | Through Boxer Capital Management, LLC Held by a company or fund the insider manages | 4,448,359 | $19.73 | $87.8M | — | Form 4, Oct 18, 2024 |
| Tango Therapeutics TNGX Common Stock | Through Boxer Capital Management, LLC Held by a company or fund the insider manages | 3,610,642 | $22.71 | $82.0M | — | Form 4, Nov 6, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 525 | Virtu Employee Holdco LLC Director, Virtu Financial | $156M |
| 526 | White Mountains Insurance Group LTD 10% owner, MediaAlpha | $155M |
| 527 | ALS Invest 1 B.V. 10% owner, Amylyx Pharmaceuticals | $154M |
| 528 | Boxer Capital Management, LLC Insider, Tango Therapeutics | $154M |
| 529 | Yorktown Energy Partners IX, L.P. 10% owner, Riley Exploration Permian | $154M |
| 530 | Third Rock Ventures V, L.P. Director, Rapport Therapeutics | $154M |
| 531 | New Enterprise Associates 14, L.P. 10% owner, Enliven Therapeutics | $153M |
Other Tango Therapeutics insiders
All TNGX insiders- Aaron I. Davis$161MDirector. #1048 overall
- Barbara Weber$37.0MDirector, Executive Chair. #3059 overall
- Malte Peters$8.3MPresident & CEO. #10064 overall
- Alexis Borisy$397KDirector. #570 overall
Questions
How much stock does Boxer Capital Management, LLC own?
Boxer Capital Management, LLC holds $154,415,169 in listed stock based on SEC filings and current prices, mostly Tango Therapeutics (TNGX). That ranks 528th on the Stock Rich List.
Is this Boxer Capital Management, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Aaron I. Davis.